Sickle Cell Treatment Demonstration Program (93.365)

Program

93.365 Sickle Cell Treatment Demonstration Program

Federal Agency

Agency: Department of Health and Human Services
Office: Health Resources and Services Administration

Authorization

Section 712(c) of the American Jobs Creation Act of 2004, P.L. 108-357.

Program Number

93.365

Last Known Status

Active

Objectives

To support demonstration projects for the development and establishment of system mechanisms and partnerships to enhance the prevention and treatment of sickle cell disease (SCD) through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and patient and provider education.

Types of Assistance

Cooperative Agreements

Uses and Use Restrictions

All funds granted should be expended solely for carrying out the approved projects in accordance with Section 712 of the Public Law 103-357.

Eligibility Requirements

Applicant Eligibility

Eligible entities include, Federally-qualified health center, as defined in section 1905(10(2)(B) of the Social Security Act (42 U.S.C. 1396d(10(2)(B), nonprofit hospital or clinic, or university health center that provides primary health care, that: (1) has a collaborative agreement with a community-based Sickle Cell Disease organization or a nonprofit entity with experience in working with individuals who have Sickle Cell Disease; and (2) demonstrates that either the Federally-qualified health center, the nonprofit hospital or clinic, the university health center, the community-based Sickle Cell Disease organization or the Sickle Cell Disease experts who serve as consultants to the project have at least 5 years of experience in working with individuals who have Sickle Cell Disease.

Beneficiary Eligibility

Projects will benefit individuals with Sickle Cell Disease and health professionals who provide care for individuals with Sickle Cell Disease.

Credentials/Documentation

Applicants should review the individual HRSA Guidance documents issued under this CFDA program for any required proof or certifications which must be submitted prior to or simultaneous with submission of an application package. OMB Circular No. A-87 applies to this program.

Application and Award Process

Preapplication Coordination

Preapplication coordination is required. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.

Application Procedure

OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. HRSA requires all applicants to apply electronically through Grants.gov.

All qualified applications will be forwarded to an objective review committee. Based on the advice of the objective review committee, the HRSA program official with delegated authority is responsible for final selection and funding decisions.

Award Procedure

Notification is made in writing by a Notice of Grant Award.

Deadlines

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time

Final decisions are made approximately 2-3 months after receipt of applications.

Appeals

Not Applicable.

Renewals

After initial award, projects may be renewed annually up to the limit of the project period upon the submission and approval of a satisfactory continuation application.

Assistance Considerations

Formula and Matching Requirements

This program has no statutory formula.

This program has no matching requirements.

This program does not have MOE requirements.

Length and Time Phasing of Assistance

Awards are made on an annual basis for the duration of the grant period, and payments are made through an Electronic Transfer System or Cash Demand System. See the following for information on how assistance is awarded/released: Grantees drawdown funds, as necessary, from the Payment Management System (PMS). PMS is the centralized web based payment system for HHS awards.

Post Assistance Requirements

Reports

Annual Reports. No cash reports are required. FSR. No expenditure reports are required. No performance monitoring is required.

Audits

In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133.

Records

Grantees are required to maintain grant accounting records for 3 years after the date they submit the FSR. If any litigation, claim, negotiation, audit, or other action involving the award has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later.

Program Accomplishments

Fiscal Year 2008: Four regional Sickle Cell Disease Collaborative Networks (Networks) were funded in FY 2006, the first year of the program. The coordinating center, along with the four grantees and a steering committee have developed project plans as a means of completing a report to Congress that includes: 1) the identification of a model protocol for implementing the recommendations of Congress regarding changes that should be made in health care and health education to persons with sickle cell disease, as well as in methods of screening for persons having the disease or are carriers; 2) the procedures for implementing this protocol at the four grantee sites; and 3) the set of methods for evaluating the degree of success that each grantee has attained and the overall effectiveness of the SCDTDP. Support is provide through on-going technical assistance, information exchange; materials review and development; collection, coordination, and distribution of program data, best practices, and findings and sustaining partnerships. Fiscal Year 2009: In FY 2009, an additional three regional Sickle Cell Disease Collaborative Networks will be funded to expand the program. Fiscal Year 2010: No Current Data Available

Financial Information

Account Identification

75-0350-0-1-550.

Obligations

(Cooperative Agreements) FY 08 $1,469,216; FY 09 est $2,845,948; FY 10 est not reported.

Range and Average of Financial Assistance

$317,304 to $400,000; $358,652.

Regulations, Guidelines and Literature

This program is subject to the provisions of 45 CFR Part 92 for State, local and tribal governments and 45 CFR Part 74 for institutions of higher education, hospitals, other nonprofit organizations and commercial organizations, as applicable.

Related Programs

93.110 Maternal and Child Health Federal Consolidated Programs

Information Contacts

Regional or Local Office

See Regional Agency Offices. Program Office: Lorriane Brown, Genetic Services Branch, Division of Services for Children with Special Health Needs, Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services, Room 18A-19, 5600 Fishers Lane, Rockville, MD 20857; Telephone: (301) 443-9775.

Headquarters Office

Lorriane Brown 5600 Fishers Lane, Room 18-A19, Rockville, Maryland 20857 Phone: (301) 443-9775

Web Site Address

www.hrsa.gov.

Examples of Funded Projects

Fiscal Year 2008: University of Cincinnati, Ohio Medical Center: Christian Community Health Centers, Chicago, Illinois: Stedman-Wade Health Services Inc. in Wade, North Carolina; and Health Services Inc. in Montgomery, Alabama. Fiscal Year 2009: No Current Data Available Fiscal Year 2010: No Current Data Available

Criteria for Selecting Proposals

General criteria are described in Program Regulations 45 CFR 51, and specific criteria are included in the program guidance materials provided with application kits.